China Biologic Products Inc news

   Watch this stock
Showing stories 1 - 10 of about 85   

Articles published

CBPO 121.26 +2.24 (1.88%)
price chart
China Biologic Products, Inc. (NASDAQ:CBPO) is Expected to Report $0.86 for Q1
According to analysts, China Biologic Products, Inc. (NASDAQ:CBPO) is expected to report earnings per share for the current fiscal quarter of $0.86.
Company Shares of China Biologic Products, Inc. Drops by -1.13%  American Trade Journal
Market Movers: China Biologic Products, Inc. (NASDAQ:CBPO), Sprint ...  Stock Transcript
Investor Insights on China Biologic Products Inc (NASDAQ:CBPO)
[PRNewswire] China Biologic Products Inc (NASDAQ:CBPO)(TREND ANALYSIS) a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its second quarter 2015 financial results on ...
Mid-Day Changers: China Biologic Products, Inc. (CBPO), Bellicum ...  WallStreet Scope
Bank of America Rating Update on China Biologic Products, Inc. (NASDAQ:CBPO)
Bank of America initiates coverage on China Biologic Products, Inc. (NASDAQ:CBPO). In the research report, Bank of America announces the target price to $135 per share on the shares.
Analyst Focus: China Biologic Products, Inc. (NASDAQ:CBPO)  Markets Daily
Zacks: Analysts Give $106.33 Consensus Price Target to China Biologic ...  WKRB News
New Lifetime High For China Biologic Products (CBPO)
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
Stock in Focus : China Biologic Products, Inc. (NASDAQ:CBPO)
China Biologic Products, Inc. (NASDAQ:CBPO) (TREND ANALYSIS) shares were traded with more than 50% increase in usual volume.
China Biologic Products Inc Bearish Signal Wp X Biologics Llc decreased Stake
Wp X Biologics Llc has filled a SC 13D/A form regarding China Biologic Products, Inc 116.98 -1.73 -1.46% . Filing Link: 000119312515224772.
Form 8-K China Biologic Products, For: Jun 15  StreetInsider.com
China Biologic Products, Inc. Analyst Rating Update
Analysts at Zacks have given a short term rating of strong buy on China Biologic Products (NASDAQ:CBPO) with a rank of 1. The company has received an average rating of 1 from 2 brokerage firms. 2 analysts have rated the company as a strong buy. China ...
China Biologic Announces Pricing of Public Offering of Common Stock  PR Newswire (press release)
Moving Stocks: China Biologic Products, Inc. (NASDAQ:CBPO), The Men's ...  StreetWise Report
New Lifetime High Reached By China Biologic Products (CBPO)
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
Stock Update: China Biologic Products, Inc. (NASDAQ:CBPO)
Investors will be intently watching the EPS number that China Biologic Products, Inc. (NASDAQ:CBPO) reports when they announce their upcoming earnings.
Company Shares of China Biologic Products, Inc. Drops by -3.8%  American Trade Journal
China Biologic Products Now Covered by Deutsche Bank (CBPO)  Dakota Financial News
Today China Biologic Products (CBPO) Hits New Lifetime High
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.